Onu Justus U, Osuji Portia N
Department of Mental Health, Faculty of Medicine, Nnamdi Azikiwe University, Awka, Nigeria.
Department of Neurosurgery, University College Hospital, Ibadan, Nigeria.
S Afr J Psychiatr. 2020 Nov 10;26:1564. doi: 10.4102/sajpsychiatry.v26i0.1564. eCollection 2020.
Despite the burgeoning data on the double burden of malnutrition (DBM) in sub-Saharan Africa, longitudinal studies to examine malnutrition amongst first-episode schizophrenia are uncommon in the modern literature.
To determine the extent of nutritional variations amongst persons with schizophrenia at intervals of 1-year treatment follow-up.
This study was conducted at the Federal Neuropsychiatric Hospital, Enugu, Nigeria.
Consecutive incident cases that fulfilled the criteria for schizophrenia were recruited into the study. After a baseline assessment, 206 incident cases of schizophrenia were followed up at 4th, 8th, 12th weeks, 6 months and 1 year for indicators of nutritional outcome. The body mass index (BMI) was used to measure the nutritional status amongst the study participants. Changes in the BMI across intervals of follow-up were examined using repeated measures analysis of variance, whereas the socio-demographic and clinical variables were evaluated as predictors of outcome using multiple regression analysis.
After 1 year of treatment with antipsychotics, the prevalence of underweight decreased from 19.9% (95% CI, 19.8% - 20.0%) at baseline to 16.0% (95% CI, 15.9% - 16.1%) at 1 year, but the prevalence of overweight/obesity increased from 29.1% (95% CI, 29.0% - 29.2%) at baseline to 43.2% (95% CI, 43.0% - 43.3%) at 1 year of follow-up. The predictors of BMI at 1 year were antipsychotic medication (32.7% variance), duration of vagrancy (24.0%) and age at onset (20.0%).
The finding of coexistence of undernutrition and overnutrition across the intervals of treatment follow-up underscores the need for comprehensive interventions to address both extremes of malnutrition amongst patients with schizophrenia.
尽管撒哈拉以南非洲地区关于营养不良双重负担(DBM)的数据不断涌现,但在现代文献中,针对首发精神分裂症患者营养不良情况的纵向研究并不常见。
确定精神分裂症患者在1年治疗随访期间营养状况变化的程度。
本研究在尼日利亚埃努古的联邦神经精神病医院进行。
将符合精神分裂症标准的连续新发病例纳入研究。在进行基线评估后,对206例精神分裂症新发病例在第4周、第8周、第12周、6个月和1年时进行随访,以获取营养状况指标。采用体重指数(BMI)来衡量研究参与者的营养状况。使用重复测量方差分析来检验随访期间BMI的变化,而社会人口统计学和临床变量则通过多元回归分析评估为结局的预测因素。
在使用抗精神病药物治疗1年后,体重过轻的患病率从基线时的19.9%(95%置信区间,19.8% - 20.0%)降至1年时的16.0%(95%置信区间,15.9% - 16.1%),但超重/肥胖的患病率从基线时的29.1%(95%置信区间,29.0% - 29.2%)升至随访1年时的43.2%(95%置信区间,43.0% - 43.3%)。1年时BMI的预测因素为抗精神病药物治疗(方差32.7%)、流浪持续时间(24.0%)和发病年龄(20.0%)。
在治疗随访期间发现营养不良和营养过剩并存的情况,凸显了采取综合干预措施以解决精神分裂症患者营养不良这两个极端情况的必要性。